Annexon (ANNX) Interest & Investment Income (2021 - 2026)
Annexon's (ANNX) quarterly Interest & Investment Income came in at -$53000.0 in Q1 2026, up 47.52% year-on-year from -$35926.2 in Q1 2025, and down 212.77% quarter-over-quarter from $47000.0 in Q4 2025.
Annexon (ANNX) Interest & Investment Income (2021 - 2026) Analysis & Trends
Annexon's Interest & Investment Income history runs 6 years deep, the most recent figure standing at -$53000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 47.52% year-over-year to -$53000.0 in Q1 2026; TTM through Mar 2026 was $7000.0, a 50.0% decrease from a year earlier, with the FY2025 full-year figure at -$41000.0, down 153.25% from the prior year.
- Interest & Investment Income slipped to -$53000.0 in Q1 2026 per ANNX's latest filing, from $47000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $164000.0 in Q3 2024 and bottomed at -$196000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $17000.0 (2025), against an average of $6176.5.
- Biggest YoY gain for Interest & Investment Income was 628.57% in 2022; the steepest drop was 684.0% in 2022.
- Year by year, Interest & Investment Income stood at $26000.0 in 2022, then jumped by 123.08% to $58000.0 in 2023, then slumped by 205.17% to -$61000.0 in 2024, then soared by 177.05% to $47000.0 in 2025, then tumbled by 212.77% to -$53000.0 in 2026.
- Per Business Quant, the three latest ANNX Interest & Investment Income figures stand at -$53000.0 (Q1 2026), $47000.0 (Q4 2025), and $17000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Annexon | 1.02 Bn | 1.02 Bn | - | -53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | -101,000.00 |
| Dec 31, 2024 | -61,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | -60,000.00 |
| Mar 31, 2022 | -196,000.00 |
| Dec 31, 2021 | -105,000.00 |
| Sep 30, 2021 | -7,000.00 |
| Jun 30, 2021 | 39,000.00 |